Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
567,029,372
-
Share change
-
-14,400,110
-
Total reported value
-
$5,101,188,907
-
Put/Call ratio
-
127%
-
Price per share
-
$9.01
-
Number of holders
-
421
-
Value change
-
-$198,579,913
-
Number of buys
-
165
-
Number of sells
-
195
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2020
As of 30 Sep 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 421 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 567,029,372 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, Capital World Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Capital International Investors, Migdal Insurance & Financial Holdings Ltd., STATE STREET CORP, Clal Insurance Enterprises Holdings Ltd, and MENORA MIVTACHIM HOLDINGS LTD..
This table shows 421 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.